1000-7431
2016 Issue 1
Precision medicine for cancer
GU Jianren;State Key Laboratory of Oncogenes and Related Genes;Shanghai Cancer Institute;Renji Hospital;Shanghai Jiao Tong University School of Medicine;
GU Jianren;State Key Laboratory of Oncogenes and Related Genes;Shanghai Cancer Institute;Renji Hospital;Shanghai Jiao Tong University School of Medicine;
..............page:1-2
MicroRNA-99b reverses chemosensitivity of breast cancer cells to doxorubicin by targeting and regulating the expression of mTOR gene
CHEN Lin;ZHONG Shanliang;ZHANG Lei;ZHANG Xiaohui;YU Dandan;ZHAO Jianhua;TANG Jinhai;Department of Oncology;Xuzhou Medical College;Department of General Surgery;Jiangsu Cancer Hospital;Clinical Laboratory Center;Jiangsu Cancer Hospital;
CHEN Lin;ZHONG Shanliang;ZHANG Lei;ZHANG Xiaohui;YU Dandan;ZHAO Jianhua;TANG Jinhai;Department of Oncology;Xuzhou Medical College;Department of General Surgery;Jiangsu Cancer Hospital;Clinical Laboratory Center;Jiangsu Cancer Hospital;
..............page:3-11
miR-34b suppresses the proliferation of bladder cancer BIU-87 cells
Lü Lei;HUANG Tao;HUANG Suibin;ZHOU Gaofeng;YUAN Jingdong;ZHANG Chuanhua;Department of Urology;Wuhan First Hospital;
Lü Lei;HUANG Tao;HUANG Suibin;ZHOU Gaofeng;YUAN Jingdong;ZHANG Chuanhua;Department of Urology;Wuhan First Hospital;
..............page:12-19
Changes of proportions of T and B lymphocytes and their activation in peripheral blood of H-ras12V transgenic hepatic tumor in mice
NIE Xin;WANG Kangwei;ZHANG Min;WANG Fujin;WANG Aiguo;WANG Jingyu;Laboratory Animal Center;Dalian Medical University;
NIE Xin;WANG Kangwei;ZHANG Min;WANG Fujin;WANG Aiguo;WANG Jingyu;Laboratory Animal Center;Dalian Medical University;
..............page:20-27
High concentration of ascorbic acid induces apoptosis of ovarian cancer cell line SKOV-3 in vitro
LIU Fang;XU Xiaoyang;YU Tinghe;Department of Obstetrics and Gynecology;Second Hospital Affiliated to Chongqing Medical University;
LIU Fang;XU Xiaoyang;YU Tinghe;Department of Obstetrics and Gynecology;Second Hospital Affiliated to Chongqing Medical University;
..............page:28-34
Gli inhibitor GANT61 inhibits epithelial-mesenchymal transition in esophageal adenocarcinoma
WANG Lei;WANG Lin;Ml Yuan;LIAO Haijiang;Department of Thoracic Surgery;Fourth Hospital of Hebei Medical University;
WANG Lei;WANG Lin;Ml Yuan;LIAO Haijiang;Department of Thoracic Surgery;Fourth Hospital of Hebei Medical University;
..............page:35-42
MicroRNA-375 regulates the anti-tumor effect of CIK cells against cervical cancer SiHa cells by inhibiting the expression of YAP gene
LI Jinhang;TAN Xueying;ZHANG Ping;Department of Gynecology;Qingdao Municipal Hospital Affiliated to Qingdao University Medical College;Cancer Stem Cell Laboratory;Qingdao Municipal Hospital Affiliated to Qingdao University Medical College;
LI Jinhang;TAN Xueying;ZHANG Ping;Department of Gynecology;Qingdao Municipal Hospital Affiliated to Qingdao University Medical College;Cancer Stem Cell Laboratory;Qingdao Municipal Hospital Affiliated to Qingdao University Medical College;
..............page:43-51
Expresssion of miRNA-1 in esophageal squamous cell carcinoma tissues and its mechanism
DU Yanyan;ZHAO Lianmei;LIU Xinbo;CAO Yu;MA Ming;SHAN Baoen;Department of Clinical Laboratory;Fourth Hospital;Hebei Medical University;Scientific Research Center;Fourth Hospital;Hebei Medical University;Department of Thoracic Surgery;Fourth Hospital;Hebei Medical University;
DU Yanyan;ZHAO Lianmei;LIU Xinbo;CAO Yu;MA Ming;SHAN Baoen;Department of Clinical Laboratory;Fourth Hospital;Hebei Medical University;Scientific Research Center;Fourth Hospital;Hebei Medical University;Department of Thoracic Surgery;Fourth Hospital;Hebei Medical University;
..............page:52-59
Efficacy and safety of bevacizumab combined with chemotherapy for patients with advanced gastric cancer:A Meta-analysis
SUN Jiaqi;JIANG Lei;YUAN Wenzhen;ZHAO Da;GUAN Quanlin;First Clinical Medical College of Lanzhou University;Department of Oncological Surgery;First Hospital of Lanzhou University;Department of Oncological Medicine;First Hospital of Lanzhou University;
SUN Jiaqi;JIANG Lei;YUAN Wenzhen;ZHAO Da;GUAN Quanlin;First Clinical Medical College of Lanzhou University;Department of Oncological Surgery;First Hospital of Lanzhou University;Department of Oncological Medicine;First Hospital of Lanzhou University;
..............page:60-69
..............page:69
Expression of CD117 in vasculogenic mimicry of epithelial ovarian cancer and its clinical significance
LIANG Jun;YANG Bo;WU Xiaohua;Department of Obstetrics and Gynecology;Bethune International Peace Hospital of People’s Liberation Army;
LIANG Jun;YANG Bo;WU Xiaohua;Department of Obstetrics and Gynecology;Bethune International Peace Hospital of People’s Liberation Army;
..............page:70-76
Clinical efficacy of high-dose hypofractioned radiotherapy with referencing PET to delineate target areas for patients with pancreatic cancer
REN Gang;WANG Yingjie;DI Yupeng;CHANG Dongshu;LI Ping;LI Hongqi;WANG Xuan;PANG Haifeng;KANG Xiaoli;ZHU Fuhai;WU Weizhang;LIU Xian;XIA Tingyi;Department of Radiation Oncology;Air Force General Hospital;People’s Liberation Army;
REN Gang;WANG Yingjie;DI Yupeng;CHANG Dongshu;LI Ping;LI Hongqi;WANG Xuan;PANG Haifeng;KANG Xiaoli;ZHU Fuhai;WU Weizhang;LIU Xian;XIA Tingyi;Department of Radiation Oncology;Air Force General Hospital;People’s Liberation Army;
..............page:77-82
Diagnosis and treatment of soft tissue osteosarcoma:A report of 10 cases and literature review
JIANG Zhenghui;ZHANG Weikang;LIN Nong;PAN Weibo;YE Zhaoming;Department of Orthopedics;The Second Affiliated Hospital of Zhejiang University School of Medicine;Department of Orthopedics;The First People’ s Hospital of Wenling;
JIANG Zhenghui;ZHANG Weikang;LIN Nong;PAN Weibo;YE Zhaoming;Department of Orthopedics;The Second Affiliated Hospital of Zhejiang University School of Medicine;Department of Orthopedics;The First People’ s Hospital of Wenling;
..............page:83-89
..............page:89
Application of triple exits linker for temperature regulation of ovarian cancer patients with ascites during hyperthermic peritoneal perfusion
WANG Baona;REN Hongtao;JIAO Jüfeng;SHEN Yaning;Department of Oncology;Second Affiliated Hospital of Xi’an Jiaotong University;
WANG Baona;REN Hongtao;JIAO Jüfeng;SHEN Yaning;Department of Oncology;Second Affiliated Hospital of Xi’an Jiaotong University;
..............page:90-95
The role of hypoxic microenvironment in the progress of tumor
QIN Chengdong;REN Zhenggang;TANG Zhaoyou;Liver Cancer Institute;Zhongshan Hospital;Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion;Ministry of Education;Department of Hepatic Oncology;Zhongshan Hospital;Fudan University;
QIN Chengdong;REN Zhenggang;TANG Zhaoyou;Liver Cancer Institute;Zhongshan Hospital;Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion;Ministry of Education;Department of Hepatic Oncology;Zhongshan Hospital;Fudan University;
..............page:96-102
Research progress in anti-tumor angiogenesis targeting rate-limiting enzyme PFKFB3 in glycolytic pathway of endothelial cells
LIU Feifei;LIU Jing;WU Wei;LIU Ying;LUO Ying;ZHANG Jihong;Laboratory of Molecular Genetics of Aging and Tumor;Faculty of Medicine;Kunming University of Science and Technology;
LIU Feifei;LIU Jing;WU Wei;LIU Ying;LUO Ying;ZHANG Jihong;Laboratory of Molecular Genetics of Aging and Tumor;Faculty of Medicine;Kunming University of Science and Technology;
..............page:103-109
Advances in IDH mutation in qlioma
GAO Yan;DENG Wenbin;GONG Wenrong;ZHANG Wenjing;Department of Medical Function;Medical College;Hubei University of Arts and Science;Department of Biochemistry and Molecular Medicine;University of California;
GAO Yan;DENG Wenbin;GONG Wenrong;ZHANG Wenjing;Department of Medical Function;Medical College;Hubei University of Arts and Science;Department of Biochemistry and Molecular Medicine;University of California;
..............page:110-115
..............page:116